Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Bionano Genomics Inc. logo

Bionano Genomics Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

Optionable: Yes  Market Cap: 100 M  90-day average vol: 942,734

Previous close: 2.93  Open: 2.9  Bid: 2.83  Ask: 2.9
52 week range    
PKI / 
Last updated: Wednesday 4th October 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


BNGO Income Statement

Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
Amortization-225052.0-225052.0-100000.0-1 M-6 M
Amortization of intangibles-100000.0-1 M-6 M
Basic EPS total-1.74-0.39-0.26-0.46
Basic weighted shares outstanding7 M15 M104 M277 M289 M
Cost of sales-9 M-7 M-6 M-14 M-22 M
Depreciation-1 M-1 M-1 M-2 M-4 M
DepreciationAndAmortization-1 M-1 M-1 M-2 M-4 M
Diluted EPS total-2.61-1.99-0.39-0.26-0.46
Diluted weighted shares outstanding7 M15 M105 M277 M289 M
GeneralAndAdministrativeExpense-556321.0-171796.0-887000.0-2 M-3 M
Gross operating profit3 M3 M3 M4 M6 M
Income before tax-18 M-30 M-41 M-78 M-131 M
Income restructuring and M&A92 M143 M
Income taxes15511.021048.029000.0-6 M2 M
Interest income2 M2 M
InterestExpenseNonOperating1 M2 M3 M927000.0298000.0
MiscOtherSpecialCharges3 M-2 M-7000.0-2 M-223000.0
Net income from total operations-18 M-30 M-41 M-72 M-133 M
NetIncomeCommonStockholders-18 M-30 M-41 M-72 M-133 M
NetIncomeContinuousOperations-18 M-30 M-41 M-72 M-133 M
NetNonOperatingInterestIncomeExpense-1 M-2 M-3 M1 M1 M
Operating income-20 M-26 M-39 M-77 M-132 M
Operating income before depreciation (EBITDA)-16 M-26 M-37 M-74 M-121 M
OperatingExpense24 M29 M41 M81 M138 M
Other income net-3 M2 M7000.02 M223000.0
OtherGandA-556321.0-171796.0-887000.0-2 M-3 M
OtherOperatingExpenses-370573.0-554867.0-2 M-1 M-2 M
Research & development expense9 M9 M10 M22 M49 M
ResearchExpense9 M9 M10 M22 M49 M
RestructringAndMnAIncome92 M143 M
SalariesAndWages-1 M-1 M-2 M-10 M-22 M
Selling Gen & administrative expense14 M20 M31 M58 M89 M
SellingAndMarketingExpense14 M20 M31 M58 M89 M
SellingExpense14 M20 M31 M58 M89 M
Special income/charges-92 M-143 M
Total Income available for interest expense (EBIT)-17 M-28 M-39 M-77 M-130 M
Total common shares outstanding10 M38 M279 M290 M306 M
Total net income-18 M-30 M-41 M-72 M-133 M
Total ordinary shares35 M35 M35 M35 M35 M
Total revenues12 M10 M9 M18 M28 M
TotalExpenses15 M22 M36 M67 M116 M
TotalRevenue12 M10 M9 M18 M28 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today